← ANALYST RATINGS · TIPRANKS

Zimmer Biomet Holdings (ZBH): analyst forecast and price target

$94.98 +0.64% close 16.10.26 · market cap $18.0B · Healthcare · Medical - Devices SPY 0.03%
Price targets and ratings of

Analyst consensus

Hold

1 Buy11 Hold0 Sell

Ratings of 12 analysts in the last 3 months · top analysts only

12-month forecast

$106+11.1% upside

Based on 12 price targets given in the last 3 months, the average target is $106, the highest $117, the lowest $97.00. The average is +11.1% from the last price of $94.98.

$80.00$100Jan 26AprJulOctJan 27AprJulOctHigh$117Average$106Low$97.00
Highest target $117 Average target $106 Lowest target $97.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Mike Kratky★★★★★★★★★★#1691 · hits 46% · avg +12.9% Leerink Partners $106 → $97.00−8.5% Hold +2.1% Assigned 12.10.26on TipRanks 07:35 +3.5%next day −0.1%
Gray Powell★★★★★★★★★★#648 · hits 58% · avg +12.0% BTIG — Hold — Reiterated 09.10.26on TipRanks Oct 12 09:45 −0.3%next day +3.5% · 5 days +8.5%
Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% Barclays $100 Hold +5.3% Initiated 07.10.26on TipRanks 03:55 −1.1%next day +0.9% · 5 days +4.7%
Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% Citi $99.00 Hold +4.2% Reiterated 05.10.26on TipRanks 07:16 +3.0%next day −2.6% · 5 days +0.2%
Name not given — $110 Buy +15.8% Reiterated 01.10.26on TipRanks Oct 2 21:45 −1.0%next day −0.5% · 5 days −0.4%
Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% Bank of America Securities $110 Hold +15.8% Reiterated 25.09.26on TipRanks Sep 24 10:15 −1.2%next day +1.0% · 5 days −1.1%
Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% Truist Financial $106 Hold +11.6% Reiterated 16.09.26on TipRanks 07:30 −1.2%next day −3.7% · 5 days −8.2%
Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% J.P. Morgan $117 Hold +23.2% Reiterated 17.08.26on TipRanks 08:07 −2.0%next day +1.6% · 5 days +4.0%
Caitlin Roberts★★★★★★★★★★#1832 · hits 65% · avg +14.7% Canaccord Genuity $83.00 → $100+20.5% Buy +5.3% Reiterated 10.08.26on TipRanks 07:30 +1.3%next day −0.2% · 5 days +0.5%
Jeff Johnson★★★★★★★★★★#1125 · hits 51% · avg +10.4% Robert W. Baird $92.00 → $104+13.0% Hold +9.5% Reiterated 06.08.26on TipRanks 09:35 −0.8%next day −1.3% · 5 days +1.2%
Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% Deutsche Bank $88.00 → $98.00+11.4% Hold +3.2% Reiterated 06.08.26on TipRanks 09:15 −0.8%next day −1.3% · 5 days +1.2%
Steven Lichtman★★★★★★★★★★#568 · hits 54% · avg +14.7% William Blair — Hold — Reiterated 06.08.26on TipRanks 09:10 −0.8%next day −1.3% · 5 days +1.2%
Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% UBS $115 → $120+4.3% Buy +26.3% Reiterated 06.08.26on TipRanks 08:00 −0.8%next day −1.3% · 5 days +1.2%
Lee Hambright★★★★★★★★★★#10167 · hits 49% · avg −1.6% Bernstein $91.00 → $93.00+2.2% Hold −2.1% Reiterated 06.08.26on TipRanks 07:55 −0.8%next day −1.3% · 5 days +1.2%
Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% Stifel Nicolaus $105 → $110+4.8% Buy +15.8% Assigned 06.08.26on TipRanks 07:55 −0.8%next day −1.3% · 5 days +1.2%
Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% BMO Capital $95.00 → $96.00+1.1% Hold +1.1% Reiterated 06.08.26on TipRanks 07:35 −0.8%next day −1.3% · 5 days +1.2%
Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% Wells Fargo $90.00 → $103+14.4% Hold +8.4% Assigned 06.08.26on TipRanks 07:06 −0.8%next day −1.3% · 5 days +1.2%
Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% Needham — Hold — Reiterated 05.08.26on TipRanks 15:10 +2.7%next day −0.8% · 5 days −0.6%
Mathew Blackman★★★★★★★★★★#2177 · hits 49% · avg +9.2% TD Cowen $109 → $115+5.5% Buy +21.1% Reiterated 05.08.26on TipRanks 14:10 +2.7%next day −0.8% · 5 days −0.6%
Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% BTIG — Hold — Reiterated 23.07.26on TipRanks Jul 27 05:48 +2.3%next day +1.8% · 5 days +5.4%
Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% Evercore ISI $120 → $110−8.3% Buy +15.8% Reiterated 06.07.26on TipRanks 08:55 +1.7%next day +0.1% · 5 days +5.1%
David Turkaly★★★★★★★★★★#11791 · hits 40% · avg −4.0% Citizens JMP $120 → $105−12.5% Buy +10.5% Reiterated 29.04.26on TipRanks 06:06 −3.3%next day +2.0% · 5 days +0.3%
David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% Goldman Sachs $88.00 Sell −7.3% Reiterated 10.02.26on TipRanks Feb 11 07:28 +2.1%next day +4.6% · 5 days +8.3%
Jayson Bedford★★★★★★★★★★#819 · hits 60% · avg +8.6% Raymond James — Hold — Downgrade 06.01.26on TipRanks 04:50 +1.7%next day −1.9% · 5 days −7.0%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Zimmer Biomet Holdings

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Rick Wise★★★★★★★★★★Stifel Nicolaus · #7800
Hits 51%256 of 500 Average return +0.1%
1 year Rick Wise★★★★★★★★★★Stifel Nicolaus · #7800
Hits 51%256 of 500 Average return +0.1%
2 years Rick Wise★★★★★★★★★★Stifel Nicolaus · #7800
Hits 51%256 of 500 Average return +0.1%

Most profitable

3 months Rick Wise★★★★★★★★★★Stifel Nicolaus · #7800
Hits 51%256 of 500 Average return +0.1%
1 year Rick Wise★★★★★★★★★★Stifel Nicolaus · #7800
Hits 51%256 of 500 Average return +0.1%
2 years Vijay Kumar★★★★★★★★★★Evercore ISI · #2375
Hits 54%204 of 376 Average return +4.8%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $106 at a price of $88.83 (+19.4%); now: $105 at $94.98 (+10.4%).

$90.00$100Sep 15Oct 1Oct 15Top analysts$106Average target$105Price$94.98

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051015492Oct 251113Nov1123Dec3113Jan 26373Feb453Mar3113Apr271May281Jun21Jul39Aug210Sep113Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy222321
Hold78191013
Sell110000

Earnings and sales forecast

Next report: 04.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $1.88 (from $1.86 to $1.91). Last quarter: $2.07.

Sales

Next quarter’s sales estimate — $2.0B (from $2.0B to $2.1B). Last quarter: $2.2B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Zimmer Biomet Holdings
  • CEO: Ivan Tornos
  • Employees: 17,000
  • 345 East Main Street, Warsaw, IN, 46580, US
  • www.zimmerbiomet.com

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Data from the stock’s TipRanks forecast page, read 9 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗